pegylated liposomal doxorubicin in combination with boretezomib (Caelyx plus Velcade) Progressive multiple myeloma
lenalidomide (Revlimid) treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant.
dexamethasone 40mg tablets (Neofordex) In adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products
carfilzomib (Kyprolis) in combination with dexamethasone alone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
carfilzomib (Kyprolis) In combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy
selinexor (Nexpovio) In combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
daratumumab (Darzalex) In combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
elotuzumab (Empliciti) Treatment of multiple myeloma in combination with lenalidomide and dexamethasone in adult patients who have received at least one prior therapy.
ixazomib (Ninlaro) in combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
